Claire Gillis, CEO, WG Consulting, Featured in March Issue of MM&M
The March 2014 issue of MM&M features an article by WG Consulting CEO Claire Gillis. WG Consulting, ghg's global healthcare market access consultancy, is a leader in aligning clinical, health economics and stakeholder analysis across all states of drug development. Their work in the healthcare realm allows them to identify current issues in the marketplace and provide real-world issues.
In this issue of MM&M, Claire utilizes her expertise in delivering evidence-based solutions to discuss "putting moves" on Big Data and what the healthcare sector can learn from consumer giants such as Amazon. Read more from her opinion piece at http://bit.ly/1dgYcu5.
WG Consulting Presents at 2014 New York Social Media Week
On February 19th, Caitlin McQuilling, Health Economist for WG Consulting, presented on behalf of "Team WG" during the Health Innovation Track for New York Social Media Week.
Now in its sixth year, Social Media Week has become a leading platform and worldwide event with local presence and global reach across Europe, North America, South America, Africa and Asia.
Team WG – consisting of Justin DiSanto, Yan Wang, and Caitlin McQuilling - was able to present at this year’s New York Social Media Week after winning Third Place in the Merck Social Health Hack. The "hackathon" provided the team with a chance to flesh out concepts and create innovative solutions that improve health literacy, manage chronic and acute illnesses, and improve overall wellbeing of the community. Team WG focused their efforts on finding a solution for Hepatitis C by designing an app, tentatively titled HepFree, to engage patients throughout their treatment and provide data to the physician and health system on adherence, side effects, and quality of life.
During New York Social Media Week, the team had the chance to present their work from the hackathon and network with major players in the health atmosphere, including Aetna, Merck, American Express, in addition to several prominent physicians and payers.
As a whole, the event provided the group with an opportunity to see first-hand how technology and social communication is becoming a growing opportunity in healthcare. Justin DiSanto stated, "It was a good experience to take part in the social aspects of healthcare. It was also great to shift from an onlooker to a participant at an event such as this."
This was the first year Social Media Week included a health track, signifying the growing importance of healthcare in the social realm.
For more information about Social Media Week, please visit http://socialmediaweek.org/.
Grey Healthcare Group & OptimizeRx Announce Partnership to Expand Offerings through EHRs
New York, N.Y., January 7, 2014—ghg (grey healthcare group) and OptimizeRx Corporation (OTCQB: OPRX) today announced an innovative partnership that will enable pharmaceutical/biotech companies and payers to better support healthcare providers and patients through their electronic health records (EHRs) and patient portals.
ghg and OptimizeRx will jointly market existing and newly developed products and services that are embedded in the doctor’s electronic workflow and provide physicians a suite of useful tools and information to support patient health. Powered by OptimizeRx’s SampleMD™ proprietary technology to automated delivery of product savings, support and information and with ghg’s premier strategic, creative and contract sales capabilities, these expanded services will provide instantaneous access to a range of information and on-demand services, including sampling, coupons, patient education, product information and (virtual) pharmaceutical rep support via the EHR.
The shifting healthcare environment has changed the way physicians work and how pharmaceutical companies support them. With a national shortage of physicians and mounting pressure to ensure positive health outcomes among patients, physicians have less and less time to see pharmaceutical representatives. More than half of physicians are not accessible to representatives, yet research shows that the top rated things physicians value from pharmaceutical/biotech companies are samples, coupons and patient education. As healthcare providers are increasingly relying on EHRs for information and workflow management, the opportunity to provide easy, on-demand tools that help physicians access valuable support is more critical than ever. The suite of expanded offerings by ghg and OptimizeRx will provide manufacturers and other healthcare companies a way to integrate their programs and offerings at point of context, directly and efficiently in physicians’ workflows.
“Today’s pay-for-performance environment puts pressure on physicians to deliver better health outcomes for patients. The more we can support the physician with impactful engagement tools the way they want them, the better they can help patients adhere to treatment plans and live healthier lives,” said Lynn O’Connor Vos, CEO of ghg. “The healthcare industry is a customer service business. And doctors are customers as well. These new tools will help pharma better support physicians with the information they need, when they need it, through the channel they access most. This will transform the physician-pharmaceutical relationship and positively impact people’s lives.”
OptimizeRx’s SampleMD™ proprietary technology is the leading platform to deliver patient savings and support within physician’s electronic workflow. Through its network of 350 EHRs reaching 250,000 healthcare providers, OptimizeRx delivers customized prescription vouchers, co-pay saving and other support programs tailored to the specific physician and patient type. Through this partnership, these platforms will be expanding new ways to further engage both the patient and physician, including a RepOnCall capability for physicians to access a live product rep, samples or schedule a future appointment. RepOnCall capabilities will be provided by OnCall, LLC, a ghg company and one of the most sophisticated contract sales organizations in the U.S.
“Our clients and platform partners are excited about further developing technologies to automate information the doctor has deemed valuable in treating their patients. ghg offers the ideal partnership to develop and deliver ‘better access to better healthcare’—which is our mission.” stated David Harrell, Chairman and Founder of OptimizeRx Corp.
About Grey Healthcare Group
ghg (grey healthcare group) is a global healthcare communications company capable of driving every aspect of healthcare communication. Headquartered in New York with offices in North America, Europe, and Asia, ghg works with leading companies to build world-class healthcare and pharmaceutical brands among medical professionals and consumers, with a unique storytelling approach that covers print, digital and television broadcast media, medical education, sales force presentations and managed access strategies. ghg is a member of the WPP Group, a global provider of advertising, branding, and marketing.
About OptimizeRx Corp.
OptimizeRx Corp. provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their medications. For more information, please go to www.optimizerxcorp.com or www.samplemd.com .
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
ghg’s Creative Directors Canevari, Reed, and Hanna to Judge Global Awards
John Canevari, ghg’s EVP and Chief Creative Officer, will be a judge on the executive jury—a panel of chief creative officers from around the world—for the 2013 Global Awards. GHG’s Shelley Hanna, VP/Executive Creative Director, and Justin Reed, SVP/Creative Director will be first-time members of the grand jury, a group of 70 creative directors who will review and select the top healthcare advertising from around the world.
When asked about her thoughts of judging the 2013 awards show, Shelley stated, “I’m sure the entries will be outstanding and I’m looking forward to seeing creative solutions from various countries around the world.“
Justin agreed, adding, “I feel there has been a lot of interesting work put into the market this year, and I’m thrilled to see what has been submitted for the competition.“
Now in its 19th year, the Global Awards is one of the world’s largest and most recognized healthcare communications awards, showcasing creativity and innovation in 150 category entries, spanning regional, national, and continental boundaries. The 2013 awards ceremony will take place on November 15th in New York City and Sydney, Australia. For more information, please visit http://www.theglobalawards.com/.
Vogel Farina Announced as Finalist in MM&M Awards
After 2 rounds of scoring by more than 100 independent industry judges, ghg’s Vogel Farina was announced as a finalist in the 2013 MM&M Awards.
Vogel Farina’s entry, My NET Manager patient app, offers carcinoid cancer and neuroendocrine tumor patients a unique opportunity to track information and set reminders on their mobile device in order to better manage their condition.
The MM&M Awards is one of the most widely recognized award showcases in healthcare marketing. The 2013 award ceremony will take place October 2nd, in New York. For more information, please visit http://awards.mmm-online.com/.
ghg Chief Engagement Officer Erin Byrne to Speak at Point of Care Summit
On Wednesday, September 18, 2013, ghg’s Chief Engagement Officer Erin Byrne will make a presentation at the CBI Point of Care Summit in Philadelphia, PA. Erin’s presentation, Reach Patients Through Effective Physician Communication, will look the impact of the Affordable Care Act on physician interaction with patients, review trends in patient communications, and discuss methods and new approaches to drive better health outcomes. Erin will also participate on a panel about The Role of Point of Care in the Multi-Channel Marketing Mix.
The Point of Care Summit is designed for pharmaceutical professionals to explore strategies to enhance brand experience, improve customer loyalty by targeting patients and healthcare professionals, and increase ROI through effective point-of-care marketing. The summit will take place September 18-19, 2013, at the Loews Hotel in Philadelphia, PA. For more information, please visit www.cbinet.com/conference/pc13068.
ghg Australia Honored With Bronze Award at the ADSA Non-Profit 2013 Awards for Work on AMRRIC
On August2nd, 2013, ghg Australia was honored with a bronze award at the ADSA Non-Profit 2013 awards in Europe. The winning entry, Uluruff, was recognized in the "film section – environment" category of the awards showcase.
The Uluruff CSA TV commercial is currently a key element in raising awareness for AMRRIC (Animal Management in Rural and Remote Indigenous Communities), an organization dedicated to supporting the health of indigenous animals and their communities. The ultimate goal of the Uluruff commercial piece is to raise awareness for the organization while encouraging Web site visits and donations.
View the Uluruff CSA TV commercial at: http://adsafestival.com/2013/08/02/winner-2013-film/.
ADSA Non-Profit is an international non-profit and social advertising award festival, dedicated exclusively to social and public communications. Since its inception in 1993, it has been the festival’s mission to focus public opinion on various global social matters. For more information, please visit http://adsafestival.com/adspotaward/.
WG Consulting Receives Partnership for Health Award
On July 12, 2013, ghg’s WG Consulting received the "Partnership for Health" award by the UK’s PharmaTimes, for their development of an innovative partnership model with Astellas Pharma, Ltd.
The model created by WG for Astellas focuses on creating real partnerships that deliver measurable outcomes, which includes meeting patient needs, and gaining an understanding of how this will ultimately benefit the company and its partners.
Both Astellas and WG recognized that, in practice, partnership working often fails to deliver for both parties. Although common goals may be identified, companies tend to focus on their own agenda while mistrusting the intentions of the other party involved. This creates a lack of shared understanding and commitment---a partnership of necessity---and a failure to establish essential honesty, respect, accountability, and trust. WG and Astellas saw that, too often, questions are raised on what actually gets delivered when there is no focus on measurable outcomes, which leads to frustration on both sides.
Astellas commissioned WG to put together a partnership model to work with the UK’s National Health Service (NHS) commissioners that is based on tangible outcomes and focuses on patient need with a clear understanding of how delivering this will benefit major stakeholders. Once the model was built on a solid foundation, the focus shifted to shared delivery with emphasis on implementation. NHS commissioners are now able to provide leadership and vision, ensuring clinical engagement.
Within this model, Astellas utilizes their relationships with clinicians, providers, and supply specialists with disease-area knowledge, and seeks to be seen as the partner of choice in joint projects within the fields of urology and urogynecology. WG is responsible for project management and delivery of specialist commissioning tasks, and will ensure that both partners meet their commitments; the company remains a key partner in ongoing delivery, and believes this innovative approach and methodology for creating partnerships has potential to be used in wider disease areas, creating real partnerships with NHS commissioners wherever increased capability and capacity is required.
For more information, please visit